Oncomed

Timisoara, Romania
Centru medical din Timișoara

About Oncomed


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Ipsen
2
Merck Sharp & Dohme LLC
2
AEterna Zentaris
1
Galena Biopharma, Inc.
1
Helsinn Healthcare SA
1
Poniard Pharmaceuticals
1
Synta Pharmaceuticals Corp.
1
TME Pharma AG
1
Vaxon Biotech
1
Total Rows: 9

Clinical Trials at Oncomed


During the past decade, Oncomed conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11000000221111002200Started TrialsCompleted Trails201520162017201820190123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Picoplatin Efficacy After Relapse
2007-04-01
Unknown status
399
Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer
2009-11-01
2013-06-01
Completed
339
A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer
2011-10-01
2014-05-01
Completed
180
Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
2011-11-01
2016-09-21
Completed
758
Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Cancer
2012-09-01
2013-12-01
Completed
12
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
2013-04-01
2017-01-30
Completed
511
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
2013-04-01
2015-12-01
Terminated
696
Efficacy Study of Vx001 Vaccine in NSCLC Patients
2012-08-01
2017-01-01
Completed
221

Rows per page:

1–11 of 11

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Oncomed" #1 sponsor was "Ipsen" with 2 trials, followed by "Merck Sharp & Dohme LLC" with 2 trials sponsored, "AEterna Zentaris" with 1 trials sponsored, "Galena Biopharma, Inc." with 1 trials sponsored and "Helsinn Healthcare SA" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Oncomed" #1 collaborator was "PSI CRO" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsIpsen: 2Ipsen: 2Merck Sharp & Dohme LLC: 2Merck Sharp & Dohme LLC: 2AEterna Zentaris: 1AEterna Zentaris: 1Galena Biopharma, Inc.: 1Galena Biopharma, Inc.: 1Helsinn Healthcare SA: 1Helsinn Healthcare SA: 1Poniard Pharmaceuticals: 1Poniard Pharmaceuticals: 1Synta Pharmaceuticals Corp.: 1Synta Pharmaceuticals Corp.: 1TME Pharma AG: 1TME Pharma AG: 1Vaxon Biotech: 1Vaxon Biotech: 1

Created with Highcharts 11.1.0Top CollaboratorsPSI CRO: 1PSI CRO: 1

Clinical Trials Conditions at Oncomed


According to Clinical.Site data, the most researched conditions in "Oncomed" are "Non-small Cell Lung Cancer Metastatic" (2 trials), "Advanced Prostate Cancer" (1 trials), "Anemia of Chronic Disease" (1 trials), "Breast Cancer With Low to Intermediate HER2 Expression" (1 trials) and "Carcinoma, Non-squamous Non-small-cell Lung" (1 trials). Many other conditions were trialed in "Oncomed" in a lesser frequency.

Clinical Trials Intervention Types at Oncomed


Most popular intervention types in "Oncomed" are "Drug" (9 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Olaparib" (2 trials), "Pembrolizumab" (2 trials), "Placebo" (2 trials) and "AEZS-108 / zoptarelin doxorubicin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Oncomed


The vast majority of trials in "Oncomed" are 7 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Clinical Trials Status at Oncomed


Currently, there are NaN active trials in "Oncomed". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Oncomed, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Oncomed, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 8Phase 3: 8Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Active, not recruiting: 2Active, not recruiting: 2Terminated: 1Terminated: 1Unknown status: 1Unknown status: 1